FRANKLIN
LAKES, N.J., Feb. 12,
2024 /PRNewswire/ -- BD (Becton, Dickinson and
Company) (NYSE: BDX), a leading global medical technology company,
today announced that it will present the next installment of its BD
Innovates series — which will highlight BD solutions that help
clinicians treat Peripheral Vascular Disease — on Monday, February 26, 2024, at 3:00 PM Eastern Time.
The BD Innovates series spotlights BD's innovation, products and
pipeline in support of its BD 2025 Strategy, with this installment
highlighting the Peripheral Vascular Disease platform within the BD
Peripheral Intervention business unit.
The live webcast of BD's presentation can be accessed from the
BD investor relations website, investors.bd.com. A replay of the
event will be available on the same webpage following its
conclusion.
About BD
BD is one of the largest global medical
technology companies in the world and is advancing the world of
health by improving medical discovery, diagnostics and the delivery
of care. The company supports the heroes on the frontlines of
health care by developing innovative technology, services and
solutions that help advance both clinical therapy for patients and
clinical process for health care providers. BD and its more than
70,000 employees have a passion and commitment to help enhance the
safety and efficiency of clinicians' care delivery process, enable
laboratory scientists to accurately detect disease and advance
researchers' capabilities to develop the next generation of
diagnostics and therapeutics. BD has a presence in virtually every
country and partners with organizations around the world to address
some of the most challenging global health issues. By working in
close collaboration with customers, BD can help enhance outcomes,
lower costs, increase efficiencies, improve safety and expand
access to health care. For more information on BD, please visit
bd.com or connect with us on LinkedIn at
www.linkedin.com/company/bd1/ and on X (formerly known as Twitter)
@BDandCo.
Contacts:
|
|
|
|
Media:
|
Investors:
|
Troy Kirkpatrick
|
Adam Reiffe
|
VP, Public
Relations
|
Sr. Director, Investor
Relations
|
858.617.2361
|
201.847.6927
|
troy.kirkpatrick@bd.com
|
adam.reiffe@bd.com
|
View original
content:https://www.prnewswire.com/news-releases/bd-to-present-next-installment-of-bd-innovates-series-spotlight-on-peripheral-vascular-disease-302059968.html
SOURCE BD (Becton, Dickinson and Company)